4//SEC Filing
INNOVUS PHARMACEUTICALS, INC. 4
Accession 0001415889-16-007485
CIK 0001411879operating
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 6:00 AM ET
Size
5.7 KB
Accession
0001415889-16-007485
Insider Transaction Report
Form 4
Damaj Bassam
DirectorPresident and CEO10% Owner
Transactions
- Award
Restricted Stock Unit
2016-11-16$0.25/sh+2,000,000$500,000→ 7,875,000 totalFrom: 2016-11-16Exp: 2026-11-16→ Common Stock (2,000,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F2]The reporting person was granted Restricted Stock Unit on November 16, 2016 of 2,000,000 shares, which were fully vested on the date of grant.
- [F3]These restricted stock units were granted pursuant to the Issuer's 2016 Equity Incentive Plan.
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001411879
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 6:00 AM ET
- Size
- 5.7 KB